US Newborns Facing Health Risks as Vitamin K Shot Refusals Surge by 57% in 2026

September 1, 2026
US Newborns Facing Health Risks as Vitamin K Shot Refusals Surge by 57% in 2026
  • A Reuters analysis of health records from over 1 million births shows a sharp rise in U.S. newborns not receiving the standard vitamin K shot at birth, with refusals up 57% in the first half of 2026 and reaching 8.1% by the end of June.

  • The trend intersects with broader debates about newborn interventions, including discussions around the hepatitis B vaccine, though official guidance continues to emphasize surveillance and information for parents and clinicians.

  • Healthcare providers report practical changes, such as clinics stocking vitamin K at primary care sites and some physicians requiring consent forms or linking circumcision policies to receiving the vitamin K shot.

  • The article cites Truveta data and references studies from JAMA and prior CDC reporting, while noting limitations and an evolving policy environment.

  • Readers are urged to discuss the figures with healthcare providers and to consider informing delivery plans in advance, since documentation can influence later infant illness evaluations.

  • Medical authorities maintain that vitamin K shots are safe and effective, with no proven link to cancer or other harms beyond standard precautions.

  • Clinicians stress ethical and medical stakes, describing refusals as a return to preventable infant morbidity and mortality, and call for transparent tracking and reporting of refusals and outcomes.

  • Anecdotal cases and expert testimony illustrate clinical concerns, including a Vanderbilt case linked to long-term brain damage due to refusal.

  • Counseling challenges are rising, with some clinics requiring signed consent to document informed refusal.

  • Health officials say data are under review and guidance is being provided to clinicians and parents, with ongoing efforts to rebuild trust and communicate the vitamin K message.

  • Policy responses include ongoing evaluation by HHS and CDC, aiming to balance public health guidance with respect for parental choice and to rebuild trust.

  • CDC continues to recommend vitamin K for all newborns while evaluating refusals and related bleeding events and emphasizes ongoing education for parents and providers.

Summary based on 14 sources


Get a daily email with more US News stories

More Stories